Publicaciones
-
Segura AG, Prohens L, Julià L, Amoretti S, RIbero M, Pino-Camacho L, Cano-Escalera G, Mane A, Rodriguez-Jimenez R, Roldan A, Sarró S, Ibañez A, Usall J, Lobo A, Garcia-Rizo C, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S, Rodríguez N, Perez-Ramos A, Salmeron S, González-Peñas J, Gurriarán X, Farré A, Esther Pousa Tomas, Zorrilla I, Mar-Barrutia L, Trabsa A, Martinez L, Sánchez-Cabezudo Á, Jiménez-López E, Pomarol-Clotet E, Salvador R, Butjosa A, Elena RA, Moreno-Izco L, Torres AMS, Saiz J, León-Quismondo L, Rivero O, González-Blanco L and De-la-Cámara C.
Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 94: 4-15.
-
König C, Copado P, Lamarca M, Guendouz W, Fischer R, Schlechte M, Acuña V, Berna F, Gaweda L, Vellido A, Nebot À, Angulo C and Ochoa S.
Data harmonization for the analysis of personalized treatment of psychosis with metacognitive training.
SCIENTIFIC REPORTS . 15(1): 10159-10159.
-
Verdaguer M, Comas Mateos, Josep Oriol and Garreta, Francesc.
Benefits of Water Aerobic Exercise on Mental Health Outcomes in Severe Mental Illness: The Effects of Sex
Women . 5(1): .
-
San L, Arranz B, Romans C, García B, Coromina M, Ortiz S, Vilaplana M, Soto V, Ruth Villaescusa Portella and Alvarós J.
Patient-reported outcome measures to assess mental and physical health status, functionality, and quality of life in patients with major depression or schizophrenia
Journal of Patient-Reported Outcomes . 9(1): 4-4.
-
Mas S, Julià L, Cuesta MJ, Crespo-Facorro B, Vázquez-Bourgon J, Spuch C, Gonzalez-Pinto A, Ibañez A, Usall J, Romero-López-Alberca C, Catalan A, Mané A and Bernardo M.
Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol
Frontiers in Psychiatry . 15: 1497565-1497565.
-
Peláez MT, López-Carrilero R, Espinosa V, Balsells S, Ochoa S and Osma J.
Efficacy of the unified protocol for transdiagnostic treatment of comorbid emotional disorders in patients with ultra high risk for psychosis: Results of a randomized controlled trial.
JOURNAL OF AFFECTIVE DISORDERS . 367: 934-943.
-
Lamarca M, Espinosa V, Acuña V, Vila R, Balsells S, Moritz S, Berna F, König C, Gaweda L, Group P, Barajas A and Ochoa S.
Reducing self-stigma in psychosis: A systematic review and meta-analysis of psychological interventions
PSYCHIATRY RESEARCH . 342: 116262-116262.
-
Núñez C, Stephan-Otto C, Roldán A, Grasa EM, Escartí MJ, Aguilar García-Iturrospe EJ, García-Martí G, de la Iglesia-Vaya M, Nacher J, Portella MJ and Corripio I.
Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker.
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 89: 47-55. Nº de citas: 1
-
Domínguez M, Roldan-Merino J, Tomás-Jiménez M, Puig Llobet M, Lluch-Canut T, Rodríguez Zunino N, Sánchez-Balcells S, Schröder A, Lundqvist LO, Escuder G and Moreno-Poyato AR.
The Spanish Adaptation of the Quality in Psychiatric Care-Forensic Inpatient (QPC-FIP) Instrument: Psychometric Properties
Healthcare . 12(22): .
-
Silvia MG, Georgina G, Marta FQ, Ochoa S, Escuder G, Rubio E, Martínez-Mondejar A, del Cacho N, Vanessa MR, ANA ESCANILLA CASAL, Balsells S and Huerta-Ramos ME.
RECAPACITA project: Comparing neuropsychological profiles in people with severe mental disorders, with and without capacity modification
INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY . 97: 102035-102035.